Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Survival of BRCA1/BRCA2-associated pT1 breast cancer patients, a cohort study

Autor: Barele, M. van, Rieborn, A., Heemskerk-Gerritsen, B.A.M., Obdeijn, I.M., Koppert, L.B., Loo, C.E., Tollenaar, R.A.E.M., Ausems, M.G.E.M., Beek, I. van de, Berger, L.P.V., Boer, M. de, Hest, L.P. van, Kets, C.M., Rookus, M., Hebon, Schmidt, M.K., Jager, A., Hooning, M.J.

Publikováno v: Breast Cancer Research and Treatment, 194, 1, pp. 159-170
Breast Cancer Research and Treatment, 194(1), 159-170. Springer, Cham
Breast Cancer Research and Treatment, 194(1), 159-170. Springer New York
Breast Cancer Research and Treatment, 194(1), 159-170. SPRINGER
HEBON 2022, ' Survival of BRCA1/BRCA2-associated pT1 breast cancer patients, a cohort study ', Breast Cancer Research and Treatment, vol. 194, no. 1, pp. 159-170 . https://doi.org/10.1007/s10549-022-06608-1
Breast Cancer Research and Treatment, 194, 159-170

Purpose Intensive screening in BRCA1/2 mutation carriers aims to improve breast cancer (BC) prognosis. Our aim is to clarify the prognostic impact of tumor size in BRCA mutation carriers with a pT1 BC, which is currently unclear. We are especially in

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::80b553cea35fcbc23d4428aaf062d6c6
https://doi.org/10.1007/s10549-022-06608-1